KATHERINE LOECKER: Open Payments
NPI 1073268157 · WESTMINSTER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,094 in 104 payments from 33 companies in 2025. Trend: 2023 $1,835 · 2024 $2,229 · 2025 $2,094
Food & beverage: $2,094
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $375 |
| Lilly USA, LLC | 12 | $236 |
| AstraZeneca Pharmaceuticals LP | 6 | $165 |
| GlaxoSmithKline, LLC. | 7 | $145 |
| Novo Nordisk Inc | 6 | $114 |
| PFIZER INC. | 5 | $94 |
| Amgen Inc. | 4 | $78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $77 |
| Eisai Inc. | 3 | $71 |
| Medtronic, Inc. | 2 | $66 |
Products named: VRAYLAR, MOUNJARO, AIRSUPRA, JARDIANCE, TRELEGY ELLIPTA, Leqembi, Kerendia, EVENITY.
Industry payments across CO — which companies pay providers there.
